Contraindications and Precautions Do NOT use AOD-9604 if you: Are pregnant, trying to conceive, or breastfeeding (no safety data in pregnancy/lactation) Have active cancer or history of malignancy (peptide effects on existing cancer unknown) Are under 18 years of age (pediatric safety not established) Have known hypersensitivity to peptides or benzyl alcohol (in bacteriostatic water) Have severe kidney or liver disease without physician clearance Use with caution and enhanced monitoring if you have: Diabetes or glucose metabolism disorders (monitor blood sugar closely despite no expected impact) Cardiovascular disease (comprehensive cardiac evaluation recommended) Thyroid disorders (monitor thyroid function during therapy) History of migraines (may increase headache frequency in susceptible individuals) Drug Interactions Limited formal drug interaction studies exist for AOD-9604
Peptide research brief BPC-157: mechanism, in vitro studies, and gaps in human evidence Common name BPC-157 Classification Synthetic peptide fragment (gastric pentadecapeptide) Sequence GEPPPGKPADDAGLV Molecular formula C62H98N16O22 Molecular weight 1419.55 Da CAS 137525-51-0 BPC-157: mechanism, in vitro studies, and gaps in human evidence The proposed bpc-157 mechanism of action centers on a pro-angiogenic signaling cascade reported across rodent and cell-culture experiments, with VEGFR2 receptor activation and downstream endothelial nitric oxide synthase (eNOS) phosphorylation as the most frequently cited nodes (Hsieh et al., 2017
Food interest decreases
At a BAC of around 0.40% or higher, the brain's control over essential bodily functionssuch as breathing, heartbeat, and temperature regulationbegins to shut down
BPC-157 is a locally acting peptide with vascular, inflammatory, and connective tissue effects
